Business and Summary of Significant Accounting Policies (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Net loss	$ 1,548,000	$ 1,420,000
Cash flow from operations	923,000	722,000
Stockholders' deficit	4,690,000	4,173,000	$ 3,507,000
Notes payable	1,730,000
Cash on Hand	133,000	114,000
Asset impairment	0	0
Research and development costs	$ 486,000	$ 350,000
Stock Options [Member]
Antidilutive shares	26,057,601	31,080,601
Warrants [Member]
Antidilutive shares	20,314,153	19,977,149
Convertible Notes [Member]
Antidilutive shares	35,138,466	24,100,887
Patent Costs [Member]
Operating expenses	$ 13,000	$ 20,000